Locally advanced lung cancer
| dc.contributor.author | Tfayli, Arafat Hussein | |
| dc.contributor.author | Sfeir, Pierre M. | |
| dc.contributor.author | Youssef, Bassem Y. | |
| dc.contributor.author | Khuri, Fadlo R. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.department | Surgery | |
| dc.contributor.department | Radiation Oncology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:43:30Z | |
| dc.date.available | 2025-01-24T11:43:30Z | |
| dc.date.issued | 2021 | |
| dc.identifier.doi | https://doi.org/10.3322/caac.21698 | |
| dc.identifier.eid | 2-s2.0-85114462769 | |
| dc.identifier.pmid | 34491576 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30301 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | CA Cancer Journal for Clinicians | |
| dc.source | Scopus | |
| dc.subject | Aged | |
| dc.subject | Antibodies, monoclonal, humanized | |
| dc.subject | Antineoplastic agents, immunological | |
| dc.subject | Carcinoma, squamous cell | |
| dc.subject | Clinical decision-making | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Lung neoplasms | |
| dc.subject | Neoadjuvant therapy | |
| dc.subject | Pneumonectomy | |
| dc.subject | Radiotherapy, intensity-modulated | |
| dc.subject | Tomography, x-ray computed | |
| dc.subject | Carboplatin | |
| dc.subject | Fluorodeoxyglucose f 18 | |
| dc.subject | Gemcitabine | |
| dc.subject | Pembrolizumab | |
| dc.subject | Immunological antineoplastic agent | |
| dc.subject | Monoclonal antibody | |
| dc.subject | Advanced cancer | |
| dc.subject | Article | |
| dc.subject | Backache | |
| dc.subject | Brain metastasis | |
| dc.subject | Cancer immunotherapy | |
| dc.subject | Cancer localization | |
| dc.subject | Cancer size | |
| dc.subject | Case report | |
| dc.subject | Clinical article | |
| dc.subject | Coronavirus disease 2019 | |
| dc.subject | Ct guided biopsy | |
| dc.subject | Disease duration | |
| dc.subject | Follow up | |
| dc.subject | Histopathology | |
| dc.subject | Human | |
| dc.subject | Human tissue | |
| dc.subject | Intensity modulated radiation therapy | |
| dc.subject | Length of stay | |
| dc.subject | Lung cancer | |
| dc.subject | Lung lobectomy | |
| dc.subject | Medical history | |
| dc.subject | Multidisciplinary team | |
| dc.subject | Multimodality cancer therapy | |
| dc.subject | Multiple cycle treatment | |
| dc.subject | Nuclear magnetic resonance imaging | |
| dc.subject | Positron emission tomography-computed tomography | |
| dc.subject | Stereotactic radiosurgery | |
| dc.subject | Thoracic spine | |
| dc.subject | Thorax wall | |
| dc.subject | Treatment response | |
| dc.subject | X-ray computed tomography | |
| dc.subject | Clinical decision making | |
| dc.subject | Diagnostic imaging | |
| dc.subject | Lung resection | |
| dc.subject | Lung tumor | |
| dc.subject | Pathology | |
| dc.subject | Squamous cell carcinoma | |
| dc.title | Locally advanced lung cancer | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1